Test animals Clause Samples

The 'Test animals' clause defines the rules and requirements for the use of animals in testing or research activities under an agreement. It typically outlines the standards for animal care, ethical treatment, and compliance with applicable laws and regulations, such as requiring adherence to institutional animal care guidelines or obtaining necessary approvals. This clause ensures that all parties involved handle test animals responsibly, thereby promoting humane treatment and legal compliance while minimizing ethical and legal risks associated with animal testing.
Test animals. Adult male and fe- male rats shall be used for testing. The rats shall be 7 to 9 weeks old and their weight range should be comparable from group to group. The animals shall be purchased from a reputable dealer and shall be permanently identified upon arrival. The animals shall be se- lected at random for the testing groups, and any animal showing signs of ill health shall not be used.
Test animals. For pharmaco- kinetics testing, adult male and female rats (▇▇▇▇▇▇▇ 344 or strain used for major toxicity testing), 7 to 9 weeks of age, shall be used. The animals should be purchased from a reputable dealer and shall be identified upon arrival at the testing laboratory. The animals shall be selected at random for the testing groups and any animal showing signs of ill health shall not be used. In all studies, unless otherwise specified, each test group shall contain at least four animals of each sex for a total of at least eight animals.
Test animals. For pharmaco- kinetics testing and dermal studies, adult male and female ▇▇▇▇▇▇▇-▇▇▇▇▇▇ rats, 7 to 9 weeks of age, shall be used. For dermal studies, young adult mini- pigs shall also be used. The animals should be purchased from a reputable dealer and shall be identified upon ar- rival at the testing laboratory. The animals shall be selected at random for the test groups and any animal show- ing signs of ill health shall not be used. In all studies, unless otherwise speci- fied, each test group shall contain at least 4 animals of each sex for a total of at least 8 animals.
Test animals. Ad u l t m a le a n d fe- m a le r a t s s h a ll be u sed fo r t es t i n g. T h e r a t s s h a ll be 7 t o 9 wee k s old a n d t h ei r weig h t r a n ge s h o u ld be co m p a r a ble f r o m g r o u p t o g r o u p. T h e a n i m a l s s h a ll be p ur c h a sed f r o m a r ep u t a ble de a le r a n d s h a ll be pe r m a n e n t l y ide n t ified u po n a rr iv a l . T h e a n i m a l s s h a ll be se- lec t ed a t r a n do m fo r t h e t es t i n g g r o u ps, a n d a ny a n i m a l s h owi n g s ig n s of ill h e a l t h s h a ll n o t be u sed.

Related to Test animals

  • Animals The Hirer shall ensure that no animals (including birds) except guide dogs are brought into the premises, other than for a special event agreed to by the Village Hall. No animals whatsoever are to enter the kitchen at any time.

  • Service Animals Humber Residence acknowledges the rights of persons with disabilities to retain their service animal while living in Residence. In order to preserve the health and safety of all people and animals living or working in the Residence environment, the Resident will notify the Residence Office that they require a service animal and will provide documentation as outlined in the Accessibility for Ontarians with Disabilities Act confirming that the Resident requires the service animal. The Resident will also complete a Service Animal Agreement with the Residence Manager or designate, and agrees to adhere to the requirements within it.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • SHOP DRAWINGS, PRODUCT DATA AND SAMPLES 4.12.1 Shop Drawings are drawings, diagrams, schedules and other, data specially prepared for the Work by the Contractor or any Subcontractor, manufacturer, supplier or distributor to illustrate some portion of the Work. 4.12.2 Product Data are illustrations, standard schedules, performance charts, instructions, brochures, diagrams and other information furnished by the Contractor to illustrate a material, product or system for some portion of the Work. 4.12.3 Samples are physical examples which illustrate materials, equipment or workmanship and establish standards by which the Work will be judged. 4.12.4 The Contractor shall review, approve and submit, with reasonable promptness and in such sequence as to cause no delay in the Work or in the work of the State or any separate contractor, all Shop Drawings, Product Data and Samples required by the Contract Documents. 4.12.5 By approving and submitting Shop Drawings, Product Data and Samples, the Contractor represents that he / she has determined and verified all materials, field measurements, and field construction criteria related thereto, or will do so, and that he / she has checked and coordinated the information contained within such submittals with the requirements of the Work and of the Contract Documents. 4.12.6 The Contractor shall not be relieved of responsibility for any deviation from the requirements of the Contract Documents by the Architect's approval of Shop Drawings, Product Data or Samples under Subparagraph 2.2.7 of these General Conditions unless the Contractor has specifically informed the Architect and the State in writing of such deviation at the time of sub- mission and the Architect and the State has given written approval to the specific deviation. The Contractor shall not be relieved from responsibility for errors or omissions in the Shop Drawings, Product Data or Samples by the Architect's approval thereof. 4.12.7 The Contractor shall direct specific attention, in writing or on resubmitted Shop Drawings, Product Data or Samples, to revisions other than those requested by the Architect on previous submittals. 4.12.8 No portion of the Work requiring submission of a Shop Drawing, Product Data or Sample shall be commenced until the submittal has been approved by the Architect as provided in Subparagraph 2.2.7 of these General Conditions. All such portions of the Work shall be in accordance with approved submittals.